Literature DB >> 2936888

The relationship between Fusobacterium species and other flora in mixed infection.

I Brook, R I Walker.   

Abstract

Mixed infections with three Fusobacterium species and seven other bacterial species were studied in a subcutaneous abscess model in mice. Fifteen Fusobacterium isolates (eight F. nucleatum, four F. necrophorum, and three F. varium) and one isolate each of Bacteroides fragilis, B. asaccharolyticus, Staphylococcus aureus, Group A beta-haemolytic streptococcus, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa were studied. Electronmicrographs showed the presence of a thin mucopolysaccharide wall before and after inoculation into mice in 12 isolates which included all of 11 Fusobacterium isolates that induced subcutaneous abscesses. After co-inoculation of Fusobacterium isolates with other species and selective therapy with antimicrobial agents, S. aureus and K. pneumoniae were found to be of equal or greater importance in abscess induction than were Fusobacterium isolates, while Fusobacterium isolates were found to be more important than Group A streptococci and E. coli. Mutual enhancement of the numbers of organisms in mixed infections was observed with Fusobacterium spp. and K. pneumoniae, P. aeruginosa or Bacteroides spp. Suppression of Fusobacterium spp. was noticed only when they were co-inoculated with Group A streptococci. The additive or synergistic capabilities of Fusobacterium species highlighted their potential pathogenicity in infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936888     DOI: 10.1099/00222615-21-2-93

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  18 in total

Review 1.  Virulence factors in anaerobic bacteria.

Authors:  T Hofstad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

2.  6-phospho-alpha-D-glucosidase from Fusobacterium mortiferum: cloning, expression, and assignment to family 4 of the glycosylhydrolases.

Authors:  C L Bouma; J Reizer; A Reizer; S A Robrish; J Thompson
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

3.  Lemierre's syndrome, reemergence of a forgotten disease: a case report.

Authors:  Anurag Kushawaha; Muhammed Popalzai; Elie El-Charabaty; Neville Mobarakai
Journal:  Cases J       Date:  2009-03-10

Review 4.  Encapsulated anaerobic bacteria in synergistic infections.

Authors:  I Brook
Journal:  Microbiol Rev       Date:  1986-12

5.  High-level association of bovine digital dermatitis Treponema spp. with contagious ovine digital dermatitis lesions and presence of Fusobacterium necrophorum and Dichelobacter nodosus.

Authors:  L E Sullivan; S R Clegg; J W Angell; K Newbrook; R W Blowey; S D Carter; J Bell; J S Duncan; D H Grove-White; R D Murray; N J Evans
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

6.  Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells.

Authors:  Veli-Jukka Uitto; Daniel Baillie; Qiang Wu; Renee Gendron; Daniel Grenier; Edward E Putnins; Arja Kanervo; James D Firth
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  Enhancement of the infectivity of Fusobacterium necrophorum by other bacteria.

Authors:  G R Smith; D Till; L M Wallace; D E Noakes
Journal:  Epidemiol Infect       Date:  1989-06       Impact factor: 2.451

8.  Sugar metabolism by fusobacteria: regulation of transport, phosphorylation, and polymer formation by Fusobacterium mortiferum ATCC 25557.

Authors:  S A Robrish; C Oliver; J Thompson
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  Sucrose fermentation by Fusobacterium mortiferum ATCC 25557: transport, catabolism, and products.

Authors:  J Thompson; N Y Nguyen; S A Robrish
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

10.  Characterization, distribution, and microbiological associations of Fusobacterium spp. in clinical specimens of animal origin.

Authors:  S S Jang; D C Hirsh
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.